Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 185 Results

Intervention Indication Therapeutic Area Year Actions
Aprocitentan for treating resistant hypertension Aprocitentan (ACT-132577; AC-080; ACT 13257; Actelion) Resistant hypertension Cardiovascular System 2023 View  |  Download
Atezolizumab with paclitaxel and carboplatin for previously untreated advanced endometrial cancer Atezolizumab (Tecentriq; MPDL3280A) , Carboplatin (Paraplatin) , Paclitaxel (Taxol; paclitaxel albumin) Endometrial cancer Female Reproductive Cancer 2023 View  |  Download
Avacincaptad pegol for the treatment of geographic atrophy secondary to age-related macular degeneration Avacincaptad pegol Age-related macular degeneration (AMD) , Geographic atrophy Ophthalmology 2023 View  |  Download
AZD3152 for preventing COVID-19 AZD3152 COVID-19 Infectious Disease 2023 View  |  Download
Basal Insulin-Fc for treating type 1 diabetes Basal Insulin-Fc Type 1 diabetes Endocrine Nutritional and Metabolic Disorders 2023 View  |  Download
Basal Insulin-Fc for type 2 diabetes mellitus Basal Insulin-Fc Type 2 diabetes Endocrine Nutritional and Metabolic Disorders 2023 View  |  Download
Benralizumab for treating hypereosinophilic syndrome Benralizumab (Fasenra; MEDI563) Hypereosinophilic syndrome (HES) Immunology 2023 View  |  Download
BI 907828 for previously untreated advanced dedifferentiated liposarcoma BI 907828 Advanced dedifferentiated liposarcoma Sarcoma 2023 View  |  Download
Bifikafusp alfa-onfekafusp alfa neoadjuvant therapy for treating resectable stage IIIB and IIIC melanoma Daromun Melanoma Skin Cancer 2023 View  |  Download
Botaretigene sparoparvovec for treating X-linked retinitis pigmentosa Botaretigene sparoparvovec Retinitis pigmentosa Ophthalmology 2023 View  |  Download
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications